In the Indian healthcare landscape, respiratory diseases continue to pose significant challenges, affecting people of all ...
To effectively manage chronic respiratory diseases like asthma and COPD, early intervention and strict adherence to doctor ...
Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...
Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published ...
Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...
For pulmonologists and their patients, increased rates of wildfire raise questions about how best to avoid wildfire smoke ...
Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...
The rising prevalence of allergic diseases such as food allergies, allergic rhinitis, asthma, and atopic dermatitis is a ...
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on APGE stock, giving a Buy rating on October 28. Tyler Van Buren has ...
While great strides have been made to ensure children have access to proper asthma care in their home and community, linking those environments to the care that children receive while in school has ...
Cedar Gate’s analysis also found that the per-event cost for treatment of flu-related illness was almost three times higher for COPD and asthma patients at $952.01, compared to average costs for ...